Exelixis Clinical Site #5

Houston, Texas 77030

0 studies enrolling now · 2 studies all time

What they study most

Epithelial Ovarian Cancer, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer, Neoplasm Malignant, Prostate Adenocarcinoma, Triple Negative Breast Cancer

Studies at this site

• Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC — Running, not enrolling
• Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101) — Stopped early